Skip to main content
. 2022 Aug 15;12(8):3561–3580.

Table 1.

The expression differences between non-response and response groups and ROC AUCs discriminating the two groups in breast cancer under various therapeutic regimens across CTR-DB datasets

CTR-DB ID CTR_Microarray_85 CTR_Microarray_57 CTR_Microarray_104
Therapeutic regimen Cyclophosphamide + Epirubicin + Fluorouracil +Docetaxel Anthracycline + Taxane Cyclophosphamide + Epirubicin + Fluorouracil + Paclitaxel
Sample size 16 36 71
LogFC -0.42 -0.52 -0.33
LogFC P-value 0.03 0.03 0.04
AUC 0.85 0.73 0.75
AUC P-value 6.1E-03 3.8E-02 8.9E-04